These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33760971)

  • 1. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions.
    North HF; Bruggemann J; Cropley V; Swaminathan V; Sundram S; Lenroot R; Pereira AM; Zalesky A; Bousman C; Pantelis C; Weickert TW; Shannon Weickert C
    Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):595-607. PubMed ID: 33760971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
    Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
    Front Immunol; 2018; 9():2230. PubMed ID: 30364161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cortical thickness and cognition with schizophrenia treatment resistance.
    Fan F; Huang J; Tan S; Wang Z; Li Y; Chen S; Li H; Hare S; Du X; Yang F; Tian B; Kochunov P; Tan Y; Hong LE
    Psychiatry Clin Neurosci; 2023 Jan; 77(1):12-19. PubMed ID: 36184782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia.
    Cui LB; Wang XY; Fu YF; Liu XF; Wei Y; Zhao SW; Gu YW; Fan JW; Wu WJ; Gong H; Lin BD; Yin H; Guan F; Chang X
    BMC Med; 2023 Jul; 21(1):250. PubMed ID: 37424013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.
    Johnsen E; Fathian F; Kroken RA; Steen VM; Jørgensen HA; Gjestad R; Løberg EM
    BMC Psychiatry; 2016 Mar; 16():60. PubMed ID: 26973142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allostatic load and reduced cortical thickness in schizophrenia.
    Chiappelli J; Kochunov P; Savransky A; Fisseha F; Wisner K; Du X; Rowland LM; Hong LE
    Psychoneuroendocrinology; 2017 Mar; 77():105-111. PubMed ID: 28027496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
    Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
    Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers and brain health indicators in children with overweight and obesity: The ActiveBrains project.
    Adelantado-Renau M; Esteban-Cornejo I; Rodriguez-Ayllon M; Cadenas-Sanchez C; Gil-Cosano JJ; Mora-Gonzalez J; Solis-Urra P; Verdejo-Román J; Aguilera CM; Escolano-Margarit MV; Verdejo-Garcia A; Catena A; Moliner-Urdiales D; Ortega FB
    Brain Behav Immun; 2019 Oct; 81():588-597. PubMed ID: 31330300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis.
    Lizano P; Lutz O; Xu Y; Rubin LH; Paskowitz L; Lee AM; Eum S; Keedy SK; Hill SK; Reilly JL; Wu B; Tamminga CA; Clementz BA; Pearlson GD; Gershon ES; Keshavan MS; Sweeney JA; Bishop JR
    Mol Psychiatry; 2021 Jul; 26(7):3430-3443. PubMed ID: 33060818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization.
    Hoang D; Xu Y; Lutz O; Bannai D; Zeng V; Bishop JR; Keshavan M; Lizano P
    Brain Behav Immun; 2022 Feb; 100():297-308. PubMed ID: 34875344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    J Affect Disord; 2013 Sep; 150(2):456-9. PubMed ID: 23684514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thickness correlates of cognitive performance in cognitively-matched individuals with and without schizophrenia.
    Hanford LC; Pinnock F; Hall GB; Heinrichs RW
    Brain Cogn; 2019 Jun; 132():129-137. PubMed ID: 31005042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thickness.
    Lin C; Gou M; Pan S; Tong J; Zhou Y; Xie T; Yu T; Feng W; Li Y; Chen S; Tian B; Tan S; Wang Z; Luo X; Li CR; Zhang P; Huang J; Elliot Hong L; Tan Y
    Neurosci Lett; 2022 Sep; 788():136826. PubMed ID: 35944595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
    Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Bora E
    Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences.
    Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral inflammation is associated with brain SPECT perfusion changes in schizophrenia.
    Fond G; Garosi A; Faugere M; Campion JY; Lancon C; Boyer L; Richieri R; Guedj E
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):905-912. PubMed ID: 34405275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders.
    Zhang L; Lizano P; Xu Y; Rubin LH; Lee AM; Lencer R; Reilly JL; Keefe RSE; Keedy SK; Pearlson GD; Clementz BA; Keshavan MS; Gershon ES; Tamminga CA; Sweeney JA; Hill SK; Bishop JR
    Schizophr Res; 2023 May; 255():69-78. PubMed ID: 36965362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 is associated with deficits in cognition and cerebral cortical thickness in first-episode schizophrenia.
    Pan S; Zhou Y; Yan L; Xuan F; Tong J; Li Y; Huang J; Feng W; Chen S; Cui Y; Yang F; Tan S; Wang Z; Tian B; Hong LE; Tan YL; Tian L
    J Psychiatry Neurosci; 2022; 47(2):E86-E98. PubMed ID: 35301253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants.
    Adamowicz DH; Wu TC; Daly R; Irwin MR; Jeste DV; Tu XM; Eyler LT; Lee EE
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110866. PubMed ID: 37742747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.